About Ligation Device
A ligation Device is tools is used to provide optimal patient surgical experience. Ligation is a method of tying a ligature firmly around a vein or other duct in the body. The large share of ligation devices can be attributed to the increasing volume of the surgical procedure leading to high demands for the product. According to the research In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. Helping healthcare practitioners achieve good tissue grip during surgeries and minimally invasive placement of ligation devices is becoming the demand for Ligation Device in the market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 7.0% |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Ligation Device market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Ethicon (Johnson and Johnson) (United States), Teleflex Incorporated (United States), Olympus (Japan), Applied Medical (United States), Cooper Surgical (United States), Genicon (United States), Grena Think Medical (United Kingdom), B.Braun (Germany) and Medtronic (Ireland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are ConMed (United States).
Segmentation Overview
AMA Research has segmented the market of Global Ligation Device market by Type (Minimally Invasive and Open Surgery), Application (Gastrointestinal & Abdominal Surgeries, Gynaecological Surgeries, Cardiovascular Surgeries and Urological Surgeries) and Region.
On the basis of geography, the market of Ligation Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Usability , the sub-segment i.e. Single-use will boost the Ligation Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Procedures, the sub-segment i.e. MIS will boost the Ligation Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Ligation Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technological advancement and increasing healthcare spending
Market Growth Drivers:
Growing Demand for Minimally Invasive Surgery
Challenges:
Post-surgical complications
Restraints:
The high cost of surgeries
Opportunities:
Growth Potential in Emerging such Regions the Asia Pacific
Market Leaders and their expansionary development strategies
In November 2023, Brandon Medical announced their collaborative venture to introduce cutting-edge medical equipment to Australia, New Zealand, and South East Asia. This strategic partnership marks a significant step towards revolutionizing patient care environments and empowering healthcare professionals
In September 2023, Integrated DNA Technologies (IDT) announced the availability of xGen NGS products designed exclusively for the Ultima Genomics UG 100TM platform. The suite of new xGen NGS tools comprised of adapters, primers, and universal blockers can support a wide range of applications, including DNA, RNA and methylation sequencing workflows, as well as IDT’s proven hybridization capture chemistry.
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Ligation Device Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.